These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Corticosteroids do not influence ovarian responsiveness to gonadotropins in patients with premature ovarian failure: a randomized, placebo-controlled trial. van Kasteren YM; Braat DD; Hemrika DJ; Lambalk CB; Rekers-Mombarg LT; von Blomberg BM; Schoemaker J Fertil Steril; 1999 Jan; 71(1):90-5. PubMed ID: 9935122 [TBL] [Abstract][Full Text] [Related]
4. Idiopathic premature ovarian failure: what is the most suitable ovarian stimulation protocol? Awwad J; Farra C; Hannoun A; Abou-Abdallah M; Isaacson K; Ghazeeri G Clin Exp Obstet Gynecol; 2013; 40(3):327-30. PubMed ID: 24283158 [TBL] [Abstract][Full Text] [Related]
5. Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Nugent D; Vandekerckhove P; Hughes E; Arnot M; Lilford R Cochrane Database Syst Rev; 2000; (4):CD000410. PubMed ID: 11034687 [TBL] [Abstract][Full Text] [Related]
6. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: a controlled trial. Nelson LM; Kimzey LM; White BJ; Merriam GR Fertil Steril; 1992 Jan; 57(1):50-5. PubMed ID: 1730330 [TBL] [Abstract][Full Text] [Related]
7. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Keay SD; Lenton EA; Cooke ID; Hull MG; Jenkins JM Hum Reprod; 2001 Sep; 16(9):1861-5. PubMed ID: 11527889 [TBL] [Abstract][Full Text] [Related]
8. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles. Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788 [TBL] [Abstract][Full Text] [Related]
9. Ovulation induction in premature ovarian failure: a placebo-controlled randomized trial combining pituitary suppression with gonadotropin stimulation. van Kasteren YM; Hoek A; Schoemaker J Fertil Steril; 1995 Aug; 64(2):273-8. PubMed ID: 7615102 [TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in Survivors. Blumenfeld Z; Zur H; Dann EJ Oncologist; 2015 Nov; 20(11):1283-9. PubMed ID: 26463871 [TBL] [Abstract][Full Text] [Related]
11. Successful pregnancy in a woman with premature ovarian failure. Fujii S; Ikeda S; Tachizaki T; Kagiya A; Saito Y Asia Oceania J Obstet Gynaecol; 1993 Jun; 19(2):177-80. PubMed ID: 8379866 [TBL] [Abstract][Full Text] [Related]
12. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome. Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738 [TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical efficacy of long- versus short-acting gonadotrophin-releasing hormone agonists for pituitary down regulation in Umemmuo MU; Efetie ER; Agboghoroma CO; Momoh JA; Ikechebelu JI Niger Postgrad Med J; 2020; 27(3):171-176. PubMed ID: 32687115 [TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders. Xia M; Zheng J BMC Pregnancy Childbirth; 2021 May; 21(1):372. PubMed ID: 33975553 [TBL] [Abstract][Full Text] [Related]
15. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles. Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223 [TBL] [Abstract][Full Text] [Related]
16. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial. Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970 [TBL] [Abstract][Full Text] [Related]
17. The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction. Zafeiriou S; Loutradis D; Michalas S Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):157-67. PubMed ID: 10943580 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in premenopausal women. Chen H; Xiao L; Li J; Cui L; Huang W Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008018. PubMed ID: 30827035 [TBL] [Abstract][Full Text] [Related]
19. Role of different GnRH agonist regimens in pituitary suppression and the outcome of controlled ovarian hyperstimulation. Filicori M; Cognigni GE; Arnone R; Carbone F; Falbo A; Tabarelli C; Ciampaglia W; Casadio P; Spettoli D; Pecorari R Hum Reprod; 1996 Nov; 11 Suppl 3():123-32. PubMed ID: 9147107 [TBL] [Abstract][Full Text] [Related]